Skip to content

BillionToOne, Inc. BLLN Deferred Revenue

Deferred Revenue at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$405.2M+4.4%
Guardant Health logo
Guardant HealthGH
$47.77M+31.6%
Natera, Inc. logo
Natera, Inc.NTRA
$36.85M+79.3%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$34M-52.8%
Illumina logo
IlluminaILMN
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$108.4M+83.8%
Gross profit$79.1M+108%
Operating income$17.8M+870%
Net income$18.0M+551%
EPS (diluted)$0.34+187%

Balance sheet

See full
Cash & equivalents$537.5M+181%
Total debt$144.2M
Total equity$505.6M+300%
Total assets$700.7M

Cash flow

See full
Operating cash flow$15.4M+488%
CapEx$4.5M+90.5%
Free cash flow$11.0M+3,842%

Valuation

See full
Market cap$4.8B

Profitability

See full
Gross margin70.4%
Operating margin-96.9%
Net margin8.4%
FCF margin-83.4%

Returns & leverage

See full
Debt / equity0.3×
Current ratio10.9×

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.

The official record: BillionToOne, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BillionToOne, Inc. 's deferred revenue?
BillionToOne, Inc. (BLLN) reported deferred revenue of $2.8M in Q1 2026.
What does deferred revenue mean?
Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.